Evaluation of the Effect of a Visio-Hearing Training Protocol on Spatial Hearing in Subjects With Hearing Loss
Launched by HOSPICES CIVILS DE LYON · Dec 2, 2019
Trial Information
Current as of May 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- For all participants (patients and normal hearing adults):
- • Ages 18 and 65
- • Normal vision (with or without correction)
- • Able to understand experimental instructions
- • Member of the social security scheme
- • Informed of the study and signed the consent form
- For hearing standards (NH):
- • - No hearing problems
- For patients (SU, uIC and bIC):
- • Regular follow-up in the ENT (Ear, nose, and throat) department of the Edouard Herriot Hospital in Lyon or the Purpan Hospital, in Toulouse
- • Unilateral deep deafness (only for SU patients)
- • Holder of one Cochlear implant for more than one year (only for uIC patients)
- • Holder of the second Cochlear implant for more than one year (only for bIC patients)
- Exclusion Criteria:
- • Oculomotor disorder
- • Bilateral vestibular areflexia
- • Neurological and/or psychiatric history
- • Person placed under legal protection, guardianship or trusteeship
- • Pregnant or nursing woman
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bron, , France
Toulouse, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials